HIV News and Research

RSS

Will 'old faithful' tuberculosis BCG vaccine work against COVID?

All over the world, except in China, the place where it all began, the COVID-19 pandemic is making its relentless way through the population. So far, it has caused nearly 34,000 deaths – and the situation in the US is still worsening with over 142,000 cases and 2,489 deaths. In Australia, the number of cases has climbed to 4,093, with 16 fatalities.

29 Mar 2020

Newly developed laboratory model helps reveal how HIV infection affects the brain

Though many negative repercussions of human immunodeficiency virus infection can be mitigated with the use of antiretroviral therapy, one area where medical advances haven't made as much progress is in the reduction of cognitive impacts.

27 Mar 2020

New test uses saliva sample to provide immediate hepatitis B diagnosis

Viruses are sneaky beings. As the coronavirus pandemic is demonstrating, they cross borders quickly and can be highly contagious before symptoms of disease break out. In many cases of infection, a clear path of transmission cannot be determined.

27 Mar 2020

SLAC structural biologist discovers a strange cavity in key tuberculosis protein

Researchers from the Department of Energy’s SLAC National Accelerator Laboratory have discovered a strange new feature of a protein that’s thought to be important in the development of tuberculosis: The protein contains a “huge” interior pocket, the likes of which has never before been seen, that appears capable of passing a wide range of other molecules into the bacterial cell.

27 Mar 2020

Is sex safe during COVID-19 pandemic?

It is not unimaginable that with so many couples locked down within the confines of their homes 24/7, that close physical proximity could result in increased sexual activity, giving rise to questions regarding how safe sex is during these troubled times. COVID-19 disease or infection with the SARS-CoV-2 virus has gripped the world and has taken the form of a pandemic affecting 175 nations and territories across the globe.

26 Mar 2020

New research initiative to investigate multi-species response to novel coronavirus

Scientists at Texas Biomedical Research Institute (Texas Biomed) today announced the launch of a comprehensive research initiative to investigate multiple animal species and their response to the novel coronavirus disease (COVID-19).

26 Mar 2020

Anteater-like animals are the missing link for coronavirus transmission between bats and humans

As scientists scramble to learn more about the SARS-CoV-2 coronavirus, two recent studies of the virus' genome reached controversial conclusions: namely, that snakes are intermediate hosts of the new virus, and that a key coronavirus protein shares "uncanny similarities" with an HIV-1 protein.

26 Mar 2020

Critical guidance to identify COVID-19 patients at risk of drug-induced sudden cardiac death

SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away.

25 Mar 2020

Trump’s boast about U.S., South Korea coronavirus testing misses the mark

Boasting about his administration's response to the coronavirus crisis — and arguing the outbreak would soon be under control — President Donald Trump claimed that recent American efforts to test widely for COVID-19 surpass those of other countries.

25 Mar 2020

New recommendations to tackle tuberculosis amid coronavirus crisis

The World Health Organization has today issued new recommendations to tackle tuberculosis, a respiratory disease, in the wake of coronavirus spreading across continents.

25 Mar 2020

Africa prepares for lockdown as COVID-19 situation worsens

Like most other continents, Africa is affected by the novel coronavirus causing COVID-19. African nations are gearing up to curb the spread of the infection by imposing travel bans and lockdowns for the populations. The picture today looks grim, but steps are being taken to address the pandemic in Africa.

24 Mar 2020

Projects to develop COVID-19 vaccines receive U.K. gov’t funding

The U.K. government backs six projects aimed to fight the coronavirus outbreak, promising $23 million (£20 million) in funding. The projects, including two focused on vaccination trials, will help fast track the development of a vaccine to stop the spread of the coronavirus, leading to the death of more than 16,500 people across the globe.

24 Mar 2020

Huge WHO trial of COVID-19 therapies begins

As the world reels from the devastating impact and the looming threat of the novel coronavirus COVID-19, researchers around the globe are racing to find a cure that will reduce symptom severity and reverse the course of the disease, freeing up more hospital space and making it possible to treat more of the severely affected cases.

24 Mar 2020

First patients enrolled in new clinical trial to evaluate potential COVID-19 treatments

Researchers from the University of Oxford have launched a new clinical trial to test the effects of potential drug treatments for patients admitted to hospital with COVID-19. The first patients have now been recruited.

23 Mar 2020

UNC researchers look to NGS for better understanding of COVID-19

It might be the future of diagnostic testing for common infections, and could prove to be a crucial tool for understanding and fighting novel viruses.

23 Mar 2020

Seattle nurses scrounge for masks to stay safe on pandemic’s front lines

As the caseload of patients with the new coronavirus grows, masks and other personal protective equipment are in short supply — and nurses in Washington state are resorting to workarounds to try to stay safe.

23 Mar 2020

CARB-X awards $2.86M to develop novel oral antibiotic to treat drug-resistant gonorrhea

Up to $2.86M has been awarded to a research team including Penn State scientists to develop a new oral antibiotic to treat multidrug-resistant gonorrhea, a sexually transmitted disease caused by bacteria that have developed resistance to all but one existing antibiotic.

20 Mar 2020

Researchers highlight urgent need for public health leadership during COVID-19 pandemic

For decades, public health officials have directed the containment of emerging pandemics - perhaps most notably - the worldwide eradication of smallpox starting in the early to mid-1960s.

19 Mar 2020

Lopinavir and ritonavir drug combo tested in severe COVID-19

Researchers from China and the United Kingdom have collaborated to conduct a clinical trial looking at the efficacy of a combination of two anti-HIV drugs lopinavir and ritonavir to combat severe cases of COVID-19. Their study titled, “A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19,” was published in the latest issue of the New England Journal of Medicine (NEJM).

19 Mar 2020

Was the novel coronavirus really sneaky in its spread to the U.S.? Experts say no

Unveiling a series of policies meant to mitigate the threat of COVID-19, President Donald Trump also sought to respond to criticism that his administration has been slow to deal with what is now a worldwide pandemic.

19 Mar 2020

HIV News and Research

Will 'old faithful' tuberculosis BCG vaccine work against COVID?

Newly developed laboratory model helps reveal how HIV infection affects the brain

New test uses saliva sample to provide immediate hepatitis B diagnosis

SLAC structural biologist discovers a strange cavity in key tuberculosis protein

Is sex safe during COVID-19 pandemic?

New research initiative to investigate multi-species response to novel coronavirus

Anteater-like animals are the missing link for coronavirus transmission between bats and humans

Critical guidance to identify COVID-19 patients at risk of drug-induced sudden cardiac death

Trump’s boast about U.S., South Korea coronavirus testing misses the mark

New recommendations to tackle tuberculosis amid coronavirus crisis

Africa prepares for lockdown as COVID-19 situation worsens

Projects to develop COVID-19 vaccines receive U.K. gov’t funding

Huge WHO trial of COVID-19 therapies begins

First patients enrolled in new clinical trial to evaluate potential COVID-19 treatments

UNC researchers look to NGS for better understanding of COVID-19

Seattle nurses scrounge for masks to stay safe on pandemic’s front lines

CARB-X awards $2.86M to develop novel oral antibiotic to treat drug-resistant gonorrhea

Researchers highlight urgent need for public health leadership during COVID-19 pandemic

Lopinavir and ritonavir drug combo tested in severe COVID-19

Was the novel coronavirus really sneaky in its spread to the U.S.? Experts say no

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News